BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36909376)

  • 1. Double‑hit primary lymphoma (MYC and BCL2) in the bilateral ovary: A case report.
    Zhang Y; Wang W; Chen T
    Oncol Lett; 2023 Apr; 25(4):141. PubMed ID: 36909376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-Hit Lymphoma (MYC and BCL6) with Involvement of Skull and Adnexal Lesions: A Case Report and a Review of the Literature.
    Minhas H; Abdelmalek C; Khan M; O'Donnell JE; Gotlieb V; Wang JC
    Am J Case Rep; 2018 Aug; 19():1035-1041. PubMed ID: 30158513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
    Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
    Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Grade B-Cell Lymphoma (HGBL) with
    Tsai CC; Su YC; Bamodu OA; Chen BJ; Tsai WC; Cheng WH; Lee CH; Hsieh SM; Liu ML; Fang CL; Lin HT; Chen CL; Yeh CT; Lee WH; Ho CL; Lai SW; Tzeng HE; Hsieh YY; Chang CL; Zheng YM; Liu HW; Yen Y; Whang-Peng J; Chao TY
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33807449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
    Bischin AM; Dorer R; Aboulafia DM
    Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
    Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI
    Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.
    Tomita N; Tokunaka M; Nakamura N; Takeuchi K; Koike J; Motomura S; Miyamoto K; Kikuchi A; Hyo R; Yakushijin Y; Masaki Y; Fujii S; Hayashi T; Ishigatsubo Y; Miura I
    Haematologica; 2009 Jul; 94(7):935-43. PubMed ID: 19535347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with
    Uchida A; Isobe Y; Uemura Y; Nishio Y; Sakai H; Kato M; Otsubo K; Hoshikawa M; Takagi M; Miura I
    BMC Clin Pathol; 2017; 17():21. PubMed ID: 29151814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular adnexal lymphoma: Subtype-specific clinical and genetic features.
    Kirkegaard MK
    Acta Ophthalmol; 2022 Oct; 100 Suppl 270():3-37. PubMed ID: 36196757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL2 and MYC dual-hit lymphoma/leukemia.
    Tomita N
    J Clin Exp Hematop; 2011; 51(1):7-12. PubMed ID: 21628855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH
    Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Double-hit Lymphomas Cases: A Molecular Cytogenetic Approach.
    Torres CH; Tirado CA
    J Assoc Genet Technol; 2018; 44(4):141-145. PubMed ID: 30521492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
    Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N
    Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
    J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of "Double-hit" and "Double-protein" expression in Primary Gastric B-cell Lymphomas.
    He M; Chen K; Li S; Zhang S; Zheng J; Hu X; Gao L; Chen J; Song X; Zhang W; Wang J; Yang J
    J Cancer; 2016; 7(10):1215-25. PubMed ID: 27390596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.
    Testo N; Olson LC; Subramaniyam S; Hanson T; Magro CM
    Am J Dermatopathol; 2016 Oct; 38(10):769-74. PubMed ID: 27391453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-hit and triple-hit high-grade B-cell lymphoma of the ocular adnexa.
    Henry RK; Bilyk JR; Evans JJ; Lao PA; Milman T
    Orbit; 2022 Oct; 41(5):624-628. PubMed ID: 33779481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aggressive B-cell lymphoma with IGH/MYC, IGH/BCL2, and IGH/CCND1 translocations].
    Nishijima A; Noguchi Y; Narukawa K; Takano H; Oshikawa G
    Rinsho Ketsueki; 2019; 60(10):1425-1430. PubMed ID: 31695002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Triple hit" lymphomas: A retrospective cytology case series of an uncommon high grade B-cell malignancy with C-MYC, BCL-2 and BCL-6 rearrangements.
    Eldessouki T; Hanley K; Hamadeh F; Oshilaja OO; Sturgis CD
    Diagn Cytopathol; 2018 Sep; 46(9):807-811. PubMed ID: 30043475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas.
    Willenbacher E; Willenbacher W; Weger R; Dominik W; Manzl C; Brunner A
    Ann Hematol; 2020 Sep; 99(9):2125-2132. PubMed ID: 32613279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.